Notification

Divine Hira Jewellers IPO is Open!

Apply for the Divine Hira Jewellers IPO through UPI in just minutes.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Wockhardt Limited Share Price

₹ 1354.25 64.44 (4.99%)

Mar 18 2025 03:30 PM Pharmaceuticals NSE: WOCKPHARMA

Wockhardt Limited Share Price Update

As of the latest trading session, Wockhardt Limited share price is currently at 1354.25, which is up by 64.44 from its previous closing. Today, the stock has fluctuated between 1288.05 and 1354.25. Over the past year, Wockhardt Limited has achieved a return of 141.73 %. In the last month alone, the return has been -8.54 %. Read More...

Wockhardt Limited Performance

Day Range

Low1288.05 High1354.25

1354.25

52 Week Range

Low 490.15 High 1679.90

1354.25

Wockhardt Limited Share Price

7506

532300

WOCKPHARMA

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

1299.70

Prev. Close

1289.80

Volume (Shares)

225889.00

Total traded value

3059.10

Upper Circuit

1354.25

Lower Circuit

1225.35

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Wockhardt Limited Fundamentals

(Standalone)

Market Cap (Cr)	19509.35
PE Ratio (TTM)	-117.76
Book Value / Share	170.15
Beta	1.35

ROE	0.00%
EPS (TTM)	0.00
Dividend Yield	0.00%
Net Profit Qtr (Cr)	-22.00

Wockhardt Limited Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	325.00
Operating Expense	353.00
Net Profit	-22.00
Net Profit Margin (%)	-6.76
Earnings Per Share (EPS)	-1.40
EBITDA	68.00
Effective Tax Rate (%)	0.00

Particulars	SEP 2024 (Values in Cr)
Revenue	370.00
Operating Expense	417.00
Net Profit	-36.00
Net Profit Margin (%)	-9.72
Earnings Per Share (EPS)	-2.34
EBITDA	60.00
Effective Tax Rate (%)	0.00

Particulars	JUN 2024 (Values in Cr)
Revenue	352.00
Operating Expense	373.00
Net Profit	6.00
Net Profit Margin (%)	1.70
Earnings Per Share (EPS)	0.39
EBITDA	107.00
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	355.00
Operating Expense	505.00
Net Profit	-126.00
Net Profit Margin (%)	-35.49
Earnings Per Share (EPS)	-8.71
EBITDA	-22.00
Effective Tax Rate (%)	0.00

Particulars	DEC 2023 (Values in Cr)
Revenue	288.00
Operating Expense	367.00
Net Profit	-74.00
Net Profit Margin (%)	-25.69
Earnings Per Share (EPS)	-5.14
EBITDA	30.00
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	1154.00
Operating Expense	1603.00
Net Profit	-422.00
Net Profit Margin (%)	-36.56
Earnings Per Share (EPS)	-29.27
EBITDA	-9.00
Effective Tax Rate (%)	0.00

Particulars	MAR 2023 (Values in Cr)
Revenue	1072.00
Operating Expense	1417.00
Net Profit	-466.00
Net Profit Margin (%)	-43.47
Earnings Per Share (EPS)	-32.40
EBITDA	-98.00
Effective Tax Rate (%)	9.16

Particulars	MAR 2022 (Values in Cr)
Revenue	1372.00
Operating Expense	1594.00
Net Profit	-140.00
Net Profit Margin (%)	-10.20
Earnings Per Share (EPS)	-11.62
EBITDA	260.00
Effective Tax Rate (%)	23.91

Particulars	MAR 2021 (Values in Cr)
Revenue	987.00
Operating Expense	1509.00
Net Profit	593.00
Net Profit Margin (%)	60.08
Earnings Per Share (EPS)	53.57
EBITDA	-239.00
Effective Tax Rate (%)	37.07

Particulars	MAR 2020 (Values in Cr)
Revenue	890.06
Operating Expense	1416.76
Net Profit	-231.12
Net Profit Margin (%)	-25.96
Earnings Per Share (EPS)	-20.88
EBITDA	-90.12
Effective Tax Rate (%)	32.66

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	218.12
ROE %	-12.34
ROCE %	-0.86
Total Debt to Total Equity	0.68
EBITDA Margin	6.22

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	232.92
ROE %	-9.21
ROCE %	-0.45
Total Debt to Total Equity	0.61
EBITDA Margin	8.45

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	267.29
ROE %	-3.06
ROCE %	1.15
Total Debt to Total Equity	0.67
EBITDA Margin	9.85

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	306.91
ROE %	27.45
ROCE %	13.00
Total Debt to Total Equity	1.03
EBITDA Margin	38.92

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	241.26
ROE %	-1.62
ROCE %	0.46
Total Debt to Total Equity	1.20
EBITDA Margin	8.87

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	116.62
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	1.17
EBITDA Margin	-0.78

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	121.74
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	1.02
EBITDA Margin	12.78

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	153.61
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	1.07
EBITDA Margin	18.95

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	146.00
ROE %	56.52
ROCE %	-7.40
Total Debt to Total Equity	1.71
EBITDA Margin	-9.83

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	89.82
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	1.64
EBITDA Margin	0.50

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	124.00
Total Assets	7683.00
Total Liabilities	7683.00
Total Equity	3662.00
Share Outstanding	144060153
Price to Book Ratio	1.26
Return on Assets (%)	-7.27
Return on Capital (%)	-10.07

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	406.00
Total Assets	8243.00
Total Liabilities	8243.00
Total Equity	4202.00
Share Outstanding	144060153
Price to Book Ratio	1.72
Return on Assets (%)	-2.96
Return on Capital (%)	-4.02

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	292.00
Total Assets	7774.00
Total Liabilities	7774.00
Total Equity	3759.00
Share Outstanding	110781153
Price to Book Ratio	2.84
Return on Assets (%)	8.82
Return on Capital (%)	11.26

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	268.46
Total Assets	8178.91
Total Liabilities	8178.91
Total Equity	3057.46
Share Outstanding	110735003
Price to Book Ratio	1.92
Return on Assets (%)	-0.84
Return on Capital (%)	-1.33

Particulars	MAR 2019 (Values in Cr)
Cash & Short Term Investments	448.65
Total Assets	7844.31
Total Liabilities	7844.31
Total Equity	3004.63
Share Outstanding	110686203
Price to Book Ratio	4.00
Return on Assets (%)	-2.47
Return on Capital (%)	-3.56

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	486.00
Total Assets	4868.00
Total Liabilities	4868.00
Total Equity	1796.00
Share Outstanding	153400936
Price to Book Ratio	5.00
Return on Assets (%)	-8.66
Return on Capital (%)	-11.77

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	37.00
Total Assets	4732.00
Total Liabilities	4732.00
Total Equity	1753.00
Share Outstanding	144060153
Price to Book Ratio	1.26
Return on Assets (%)	-9.84
Return on Capital (%)	-13.82

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	207.00
Total Assets	5798.00
Total Liabilities	5798.00
Total Equity	2212.00
Share Outstanding	144060153
Price to Book Ratio	1.72
Return on Assets (%)	-2.41
Return on Capital (%)	-3.68

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	138.00
Total Assets	4895.00
Total Liabilities	4895.00
Total Equity	1606.00
Share Outstanding	110781153
Price to Book Ratio	2.84
Return on Assets (%)	12.11
Return on Capital (%)	18.42

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	157.48
Total Assets	4759.51
Total Liabilities	4759.51
Total Equity	994.62
Share Outstanding	110735003
Price to Book Ratio	1.92
Return on Assets (%)	-4.85
Return on Capital (%)	-9.65

Particulars	MAR 2024 (Values in Cr)
Net Income	-420.00
Cash from Operations	249.00
Cash from Investing	-137.00
Cash from Financing	334.00
Net change in Cash	416.00
Free Cash Flow	308.00

Particulars	MAR 2023 (Values in Cr)
Net Income	-624.00
Cash from Operations	164.00
Cash from Investing	-125.00
Cash from Financing	-315.00
Net change in Cash	-287.00
Free Cash Flow	206.00

Particulars	MAR 2022 (Values in Cr)
Net Income	-411.00
Cash from Operations	510.00
Cash from Investing	-201.00
Cash from Financing	-71.00
Net change in Cash	141.00
Free Cash Flow	628.00

Particulars	MAR 2021 (Values in Cr)
Net Income	916.00
Cash from Operations	-170.00
Cash from Investing	1470.00
Cash from Financing	-1171.00
Net change in Cash	12.00
Free Cash Flow	-89.00

Particulars	MAR 2020 (Values in Cr)
Net Income	-196.68
Cash from Operations	666.12
Cash from Investing	-155.53
Cash from Financing	-679.58
Net change in Cash	-186.15
Free Cash Flow	696.77

Particulars	MAR 2024 (Values in Cr)
Net Income	-422.00
Cash from Operations	188.00
Cash from Investing	-75.00
Cash from Financing	346.00
Net change in Cash	459.00
Free Cash Flow	190.00

Particulars	MAR 2023 (Values in Cr)
Net Income	-513.00
Cash from Operations	76.00
Cash from Investing	-3.00
Cash from Financing	-236.00
Net change in Cash	-168.00
Free Cash Flow	76.00

Particulars	MAR 2022 (Values in Cr)
Net Income	-184.00
Cash from Operations	-14.00
Cash from Investing	-244.00
Cash from Financing	430.00
Net change in Cash	93.00
Free Cash Flow	38.00

Particulars	MAR 2021 (Values in Cr)
Net Income	861.00
Cash from Operations	-452.00
Cash from Investing	1014.00
Cash from Financing	-480.00
Net change in Cash	-29.00
Free Cash Flow	-435.00

Particulars	MAR 2020 (Values in Cr)
Net Income	-338.32
Cash from Operations	222.01
Cash from Investing	-16.15
Cash from Financing	-273.97
Net change in Cash	-68.61
Free Cash Flow	240.32

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L	35.42	19.04	1.93	271.44	34.11 / 77.70
BLISS GVS PHARMA LTD	112.50	14.74	1.17	1185.42	92.25 / 184.95
CIPLA LTD	1493.05	24.17	4.25	120580.95	1317.60 / 1702.00
FERMENTA BIOTECH LIMITED	249.90	20.70	2.53	735.48	145.00 / 449.00

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L	35.42	21.34	6.02	271.44	34.11 / 77.70
AMRUTAJAN HEALTH LTD	587.10	34.41	5.69	1697.34	548.05 / 861.40
ASTRAZENECA PHARMA IND LT	7719.65	115.13	28.40	19299.13	4050.15 / 8139.85
BLISS GVS PHARMA LTD	112.50	14.61	1.15	1185.42	92.25 / 184.95

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 1291.20
26 Days 1323.30
10 Days 1289.20
50 Days 1345.10
12 Days 1291.90
100 Days 1298.00
20 Days 1310.20
200 Days 1130.60

1294.15
PIVOT

First Resistance	1302.65
Second Resistance	1315.50
Third Resistance	1324.00

First Support	1281.30
Second Support	1272.80
Third Support	1259.95

RSI	46.40
MACD	-31.43
Commodity Channel Index (CCI)	-0.45

ADX	56.49
Williams % R	-24.78

Wockhardt Limited Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

34.54 Promoter Holdings

49.09 FII

6.54 DII

9.81 Promoter Shares(Pledge Percentage)

16.98

Name	Category	Shares	Shares%
Themisto Trustee Company Private Limited	Shareholding of Promoter and Promoter Group	6.5244744E7	40.16
Pasithee Trustee Company Private Limited	Shareholding of Promoter and Promoter Group	4420000.0	2.72
Ananke Trustee Company Private Limited	Shareholding of Promoter and Promoter Group	3810693.0	2.35
Callirhoe Trustee Company Private Limited	Shareholding of Promoter and Promoter Group	3112079.0	1.92
Estate Of Late Mr. Rakesh Jhunjhunwala	Public Shareholding	2837005.0	1.75
3p India Equity Fund 1	Public Shareholding	2253682.0	1.39
Hdfc Large And Mid Cap Fund	Public Shareholding	1827087.0	1.12
Tata Mutual Fund - Tata Small Cap Fund	Public Shareholding	1777133.0	1.09
Icici Prudential Elss Tax Saver Fund	Public Shareholding	1717017.0	1.06
Callirhoe Trustee Company Private Limite	Shareholding of Promoter and Promoter Group	936751.0	0.58
Pasithee Trustee Company Private Limited	Shareholding of Promoter and Promoter Group	650000.0	0.4
Habil F Khorakiwala	Shareholding of Promoter and Promoter Group	595486.0	0.37
Murtaza Habil Khorakiwala	Shareholding of Promoter and Promoter Group	294060.0	0.18
Huzaifa Habil Khorakiwala	Shareholding of Promoter and Promoter Group	280800.0	0.17
Ananke Trustee Company Private Limited	Shareholding of Promoter and Promoter Group	274530.0	0.17
Themisto Trustee Company Private Limited	Shareholding of Promoter and Promoter Group	130000.0	0.08
Khorakiwala Holdings And Investments Private Limited	Shareholding of Promoter and Promoter Group	0.0	0.0
Palanpur Holdings And Investments Private Limited	Shareholding of Promoter and Promoter Group	0.0	0.0
Dartmour Holdings Private Limited	Shareholding of Promoter and Promoter Group	0.0	0.0
Zahabiya Khorakiwala	Shareholding of Promoter and Promoter Group	0.0	0.0
Muayyad H Khorakiwala	Shareholding of Promoter and Promoter Group	1800.0	0.0
Miqdad H Khorakiwala	Shareholding of Promoter and Promoter Group	2340.0	0.0
Nafisa Habil Khorakiwala	Shareholding of Promoter and Promoter Group	5565.0	0.0

Wockhardt Limited

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type
2016-11-17	10.0	Interim	2016-11-19	Equity shares	2014-11-13	20.0	Interim	2014-11-15	Equity shares	2014-02-17	5.0	Interim 2	2014-02-19	Equity shares	2013-11-07	5.0	Interim	2013-11-08	Equity shares	2013-08-22	5.0	Final	2013-08-24	Equity shares	2008-04-17	2.5	Final	2008-04-22	Equity shares	2007-10-26	8.75	Interim	2007-10-29	Equity shares	2007-03-22	5.0	Interim	2007-03-23	Equity shares	2006-06-21	0.0	Final	2006-06-23	Equity shares

Wockhardt Share Result Highlights

Wockhardt's performance shows a 7.44% YoY sales growth in Q2 of this financial year, with revenue rising to ₹809 crore from ₹753 crore a year ago. It is also 70 crore higher than the first quarter of this year. However, the company reported a net loss of ₹16 crore, though this represents a significant 78% improvement in YoY profit, when compared to the same quarter last year. The operating profit reached ₹110 crore with a stable OPM of 14%, reflecting operational efficiency despite challenges.

Wockhardt Share Annual Reports

For FY24, Wockhardt’s revenue reached ₹2,798 crore, marking a 5.55% growth from ₹2,651 crore in FY23. However, net losses persisted, narrowing slightly to ₹472 crore compared to ₹621 crore the prior year. The company’s EPS stood at -₹30.18, reflecting ongoing challenges in profitability. Over the past three years, Wockhardt has shown a slight recovery in sales growth (1%), but negative returns on equity (-8% on average) highlight the need for operational improvements. These figures indicate Wockhardt’s slow but gradual turnaround amid a challenging pharmaceutical landscape. Interestingly, Wockhardt’s share price in the last 1 year period surged to 292%.

Wockhardt Share Dividend

Wockhardt did not declare any dividends for FY24, as it prioritised stabilising operations amid ongoing losses. The company’s dividend yield remains at 0%, reflecting its focus on reinvesting to address its financial challenges. Despite a 78% YoY improvement in Q2 profits, net losses and negative equity returns (-12% last year) underscore the difficulty of achieving dividend payouts. A noteworthy factor, here, is Wockhardt’s compounded profit growth of 16% over three years.

About Wockhardt Limited

Learn More About Stocks

Moody’s Affirms IndusInd Bank Ratings, Places BCA on Review for Downgrade

Moody’s has affirmed IndusInd Bank’s Ba1 rating with a stable outlook but placed its Baseline Credit Assessment (BCA) on review for downgrade due to risk concerns.

18 Mar, 2025 | 2 Min. read

Manappuram Finance Board to Consider Fundraising Proposals on March 20

Manappuram Finance’s board to meet on March 20 to discuss fundraising through equity shares, warrants, or debt securities. Shares remain in focus amid stake sale reports.

18 Mar, 2025 | 3 Min. read

Tata Motors Incorporates Digital.AI Labs to Expand in IT Sector

Tata Motors has launched Tata Motors Digital.AI Labs Limited, a wholly owned subsidiary focused on IT and digital solutions. Tata Motors share price remains in focus.

18 Mar, 2025 | 3 Min. read

IRCON Wins Rs.285 Crore Order in Meghalaya Secretariat Project

IRCON International secures a Rs.285 crore share in a Rs.1,096.17 crore EPC contract for a new Secretariat Complex in Meghalaya. Project completion is set for 36 months.

18 Mar, 2025 | 3 Min. read

Zydus Life Gets Final USFDA Approval for Eluxadoline Tablets

Zydus Lifesciences Ltd. receives final USFDA approval for Eluxadoline Tablets, 75 mg and 100 mg, securing 180-day shared exclusivity in the US market.

17 Mar, 2025 | 2 Min. read

Galaxy Surfactants Declares ₹18 Per Share Interim Dividend for FY25

Galaxy Surfactants announces an interim dividend of ₹18 per equity share for FY25. The record date is March 20, 2025, with payment to be made within 30 days.

17 Mar, 2025 | 2 Min. read

KEC International Secures Orders Worth Rs 1,267 Crores Across Sectors

KEC International secures new orders worth Rs 1,267 crores in T&D and cables. The company’s YTD order intake surpasses Rs 23,300 crores, reflecting 35% growth.

17 Mar, 2025 | 2 Min. read

Dalmia Bharat Begins Production at 2.4 MTPA Cement Unit in Assam

Dalmia Bharat starts commercial production at its expanded 2.4 MTPA cement grinding unit in Assam, increasing its total manufacturing capacity to 49 MTPA.

17 Mar, 2025 | 2 Min. read

Coromandel International Acquires 53% Stake in NACL Industries for ₹820 Crore

Coromandel International Ltd acquires a 53.13% stake in NACL Industries for ₹820 crore, expanding its presence in the crop protection market. Learn more about the deal.

13 Mar, 2025 | 3 Min. read

BEML Signs MoUs with Siemens India and Dragflow Italy for Rail, Dredging

BEML partners with Siemens India for rail solutions and Dragflow Italy for dredging. The collaboration expands BEML’s presence in key infrastructure sectors.

13 Mar, 2025 | 3 Min. read

We have something for everyone

Explore More Investment Options

Start Investing

Stocks

Secure and enhance your financial future today

Invest

IPOs

Your gateway to future financial opportunities

Invest

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x

Invest

US Stocks

Discover opportunities to invest in elite FAANG stocks

Invest

Additional FAQs

1. Who is the CEO of Wockhardt Ltd?

Dr. Habil Khorakiwala is the Founder and Chairman of Wockhardt Ltd, while Dr. Murtaza Khorakiwala is the company’s Managing Director.

2. When was Wockhardt Ltd established?

Wockhardt Ltd was established in 1967 and has grown into a global pharmaceutical and biotechnology company with a strong focus on innovation.

3. What factors influence the Wockhardt Share Price?

Wockhardt’s share price is influenced by factors such as product pipeline development, regulatory approvals, operational performance, and demand for its pharmaceutical offerings globally.

4. Is Wockhardt Ltd debt free?

No, Wockhardt Ltd is not debt free, as the company utilises financing to support its research, development, and expansion activities.

5. What is the CAGR of Wockhardt Share?

The CAGR of Wockhardt’s share is 5% over 10 years, 41% over 5 years, and 50% over 3 years.

6. How has the Wockhardt Share Price performed over the past year?

Over the past year, Wockhardt’s share price has seen a meteoric rise of 292%, driven by positive developments in its product offerings and improved financial performance.

Frequently Asked Questions

What is the Share Price of Wockhardt Ltd?

Answer Field: The share price of Wockhardt Ltd for NSE is ₹ 1354.25 and for BSE is ₹ 1353.95.

What is the Market Cap of Wockhardt Ltd?

Answer Field: The market cap of Wockhardt Ltd for NSE is ₹ 1,95,09.35 Cr. and for BSE is ₹ 1,95,05.02 Cr. as of now.

What is the 52 Week High and Low of Wockhardt Ltd?

Answer Field: The 52 Week High and Low of Wockhardt Ltd for NSE is ₹ 1679.90 and ₹ 490.15 and for BSE is ₹ 1678.60 and ₹ 489.20.

How to Buy Wockhardt Ltd share?

Answer Field: You can trade in Wockhardt Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Wockhardt Ltd?

Answer Field: The 1 year returns on the stock has been 141.73%.

What is the Current Share Price of Wockhardt Ltd?

Answer Field: Wockhardt Ltd share price is for NSE ₹ 1354.25 & for BSE ₹ 1353.95 as on Mar 18 2025 03:30 PM.

What is the Market Cap of Wockhardt Ltd Share?

Answer Field: The market cap of Wockhardt Ltd for NSE ₹ 1,95,09.35 & for BSE ₹ 1,95,05.02 as on Mar 18 2025 03:30 PM.

What is the P/E Ratio of Wockhardt Ltd Share?

Answer Field: As on Mar 18 2025 03:30 PM the price-to-earnings (PE) ratio for Wockhardt Ltd share is -117.76.

What is the PB ratio of Wockhardt Ltd Share?

Answer Field: As on Mar 18 2025 03:30 PM, the price-to-book (PB) ratio for Wockhardt Ltd share is 170.15.

How to Buy Wockhardt Ltd Share?

Answer Field: You can trade in Wockhardt Ltd shares with Bajaj Broking by opening a demat accountopens in a new tab.

How to Buy Wockhardt Ltd Share on Bajaj Broking App?

Answer Field

To buy Wockhardt Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Wockhardt Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Scan to download

Download from App Store

Download from Play Store

9 lakh+ Users

4.3+ App Rating

4 Languages

₹4300+ Cr MTF Book

Open Demat Account

Divine Hira Jewellers IPO is Open!

Open a Free Demat Account

Trade Now, Pay Later with up to 4x

Track Market Movers Instantly

Wockhardt Limited Share Price

Wockhardt Limited Share Price Update

Wockhardt Limited Performance

Day Range

52 Week Range

Wockhardt Limited Share Price

Open Price

1299.70

Prev. Close

1289.80

Volume (Shares)

225889.00

Total traded value

3059.10

Upper Circuit

1354.25

Lower Circuit

1225.35

Wockhardt Limited Fundamentals

Wockhardt Limited Financials

Revenue

Net income

Technicals

Over 1 Month

-8.54

Over 3 Months

-12.97

Over 6 Months

30.24

Over 1 Year

141.73

Over 3 Years

64.02

Over 5 Years

46.78

Wockhardt Limited Future

Future: Price

Discount/Premium

Active Calls

Active Puts

Wockhardt Limited Shareholding Pattern

Stock Holding

View Live Stock Screeners

Holding

Public

34.54

Promoter Holdings

49.09

FII

6.54

DII

9.81

Promoter Shares(Pledge Percentage)

16.98

Holding %

Pledges % of promoter shares %

MF Holding %

FII Holding %

Wockhardt Limited

Wockhardt Share Result Highlights

Wockhardt Share Annual Reports

Wockhardt Share Dividend

About Wockhardt Limited

Companies Owned by Wockhardt Limited

Learn More About Stocks

Moody’s Affirms IndusInd Bank Ratings, Places BCA on Review for Downgrade

Manappuram Finance Board to Consider Fundraising Proposals on March 20

Tata Motors Incorporates Digital.AI Labs to Expand in IT Sector

IRCON Wins Rs.285 Crore Order in Meghalaya Secretariat Project

Explore More Investment Options

Stocks

IPOs

MTF

US Stocks

Additional FAQs

Frequently Asked Questions